Spots Global Cancer Trial Database for lung cancer stage iii

Every month we try and update this database with for lung cancer stage iii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy	NCT04305613	Cardiotoxicity Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic...	Chemoradiation	18 Years -	Abramson Cancer Center at Penn Medicine
Self-System Therapy for Older Adults With Lung Cancer	NCT04057196	Lung Cancer Sta... Lung Cancer Sta...	Self-System The...	65 Years - 100 Years	Duke University
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer	NCT06086574	Lung Cancer Sta...		18 Years -	University of Manchester
Accelerated Pulmonary Rehabilitation in the Preoperative Period	NCT06432972	Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta...	Pulmonary Rehab	18 Years -	University of Vermont
Accelerated Pulmonary Rehabilitation in the Preoperative Period	NCT06432972	Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta...	Pulmonary Rehab	18 Years -	University of Vermont
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)	NCT05258448	Cardiac Toxicit... Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... Cardiac Disease	Chemoradiothera...	18 Years -	Odense University Hospital
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer	NCT05994339	Lung Cancer Sta...	Almonertinib	18 Years - 80 Years	Laibin People's Hospital
Resilience Measurement in Older Adults With Late-Stage Lung Cancer	NCT04825912	Lung Cancer Sta... Lung Cancer Sta...	Self System The...	65 Years - 100 Years	Duke University
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer	NCT05994339	Lung Cancer Sta...	Almonertinib	18 Years - 80 Years	Laibin People's Hospital
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC	NCT03141359	Lung Cancer Sta... Lung Cancer Sta... Non Small Cell ...	SBRT Carboplatin Paclitaxel cis Platinum Etoposide IMRT Durvalumab	18 Years -	Wake Forest University Health Sciences
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery	NCT04991025	Lung Cancer Lung Cancer Sta... Lung Cancer Sta...	Cisplatin Pemetrexed Gemcitabine Carboplatin Certolizumab Nivolumab	18 Years -	Memorial Sloan Kettering Cancer Center
Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.	NCT04364776	Lung Cancer Lung Cancer Sta...	Durvalumab	18 Years - 80 Years	IRCCS Policlinico S. Matteo
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants	NCT05358691	Lung Cancer Sta...	AN0025	18 Years -	Rutgers, The State University of New Jersey
Accelerated Pulmonary Rehabilitation in the Preoperative Period	NCT06432972	Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta...	Pulmonary Rehab	18 Years -	University of Vermont
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC	NCT03872661	Lung Cancer Sta...	IBI308 Bevacizumab Pemetrexed Carboplatin Thoracic surger...	18 Years - 75 Years	Sun Yat-sen University
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer	NCT04003246	Non Small Cell ... Lung Cancer Sta...	Thoracic RT and... Consolidative D...	18 Years -	University of Texas Southwestern Medical Center
Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC	NCT06111807	Lung Cancer Sta...	ctDNA	18 Years -	University Medical Center Groningen
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery	NCT04991025	Lung Cancer Lung Cancer Sta... Lung Cancer Sta...	Cisplatin Pemetrexed Gemcitabine Carboplatin Certolizumab Nivolumab	18 Years -	Memorial Sloan Kettering Cancer Center
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy	NCT04305613	Cardiotoxicity Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic...	Chemoradiation	18 Years -	Abramson Cancer Center at Penn Medicine
Self-System Therapy for Older Adults With Lung Cancer	NCT04057196	Lung Cancer Sta... Lung Cancer Sta...	Self-System The...	65 Years - 100 Years	Duke University
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer	NCT04003246	Non Small Cell ... Lung Cancer Sta...	Thoracic RT and... Consolidative D...	18 Years -	University of Texas Southwestern Medical Center
Induction Chemo-Nivo in Unresectable Stage III NSCLC	NCT06003075	Lung Cancer, No... Lung Cancer Sta...	Nivolumab and C... Nivolumab Post Induction ... Post Induction ...	18 Years -	University of Kentucky

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: